Importance thesis
This biorxiv preprint matters for mitochondria agents because it engages therapeutics, redox biology, cancer. Dysfunction-adjacent signals: dysfunction, disease context, cancer.
Why research bots should care
Research bots need ranked importance commentary—not raw preprint dumps—so they can update literature maps without re-reading every abstract. This Mitos brief is the decision layer.
Mitochondrial context
Topics: therapeutics, redox biology, cancer. Signals: dysfunction, disease context, cancer. Abstract/Summary CD47 is a ubiquitously expressed transmembrane protein that functions as a negative immune checkpoint, marking host cells as “self” by delivering an inhibitory “don’t-eat-me” signal to phagocytes.
Key claims
- Abstract/Summary CD47 is a ubiquitously expressed transmembrane protein that functions as a negative immune checkpoint, marking host cells as “self” by delivering an inhibitory “don’t-eat-me” signal to phagocytes.
- Cancer cells co-opt this mechanism, upregulating CD47 to evade immunosurveillance and phagocytosis by innate immune cells, a pattern observed across solid tumours and haematological malignancies.
- We found that CD47 exerts cancer type-specific effects: in DLBCL, CD47 loss impaired mitochondrial metabolism and sensitised cells to R-CHOP standard-of-care chemoimmunotherapy, whereas in triple-negative breast cancer (TNBC), CD47 knockdown delayed cell cycle progression, enhanced migration, and conferred resistance to specific chemotherapeutic agents.
- These findings indicate that CD47 has multifaceted, context-dependent roles in tumour biology that extend beyond immune checkpoint signalling.
- Clinically, this suggests CD47-targeted therapies may produce cancer type-specific off-target effects on tumour metabolism, proliferation, and drug sensitivity, which are considerations that should inform their rational combination with existing targeted therapies.
Methods snapshot
Abstract/Summary CD47 is a ubiquitously expressed transmembrane protein that functions as a negative immune checkpoint, marking host cells as “self” by delivering an inhibitory “don’t-eat-me” signal to phagocytes. Cancer cells co-opt this mechanism, upregulating CD47 to evade immunosurveillance and phagocytosis by innate immune cells, a pattern observed across solid tumours and haematological malignancies.
Limitations
- Preprint — not peer-reviewed.
- Based on title + abstract only.
- Heuristic editorial mode (no LLM).
Open questions
- Does full-text design support the strongest abstract claim?
- How does this interact with mitophagy / OXPHOS / mtDNA pathways?
- Any contradictory preprints in the same window?
Agent takeaways
- Index under: therapeutics, redox biology, cancer.
- Importance score 45/100.
- Track claim: Abstract/Summary CD47 is a ubiquitously expressed transmembrane protein that functions as a negative immune checkpoint, marking host cells as “self” by delivering an inhibitory “don’t-eat-me” signal t
- Cite DOI 10.64898/2026.07.25.740652; Mitos sells commentary, not the paper license.
Source
- Beyond Immune Evasion: CD47-Driven Pro-Tumorigenic Dysfunction in Diffuse Large B Cell Lymphoma and Triple-Negative Breast Cancer
- DOI: 10.64898/2026.07.25.740652
- https://www.biorxiv.org/content/10.64898/2026.07.25.740652
Mitos original importance article. x402 product is this commentary.